AURA Valuation

Aura Biosciences Inc (AURA) has a current Price-to-Book (P/B) ratio of 2.63. Compared to its 3-year average P/B ratio of 2.20 , the current P/B ratio is approximately 19.30% higher. Relative to its 5-year average P/B ratio of 2.40, the current P/B ratio is about 9.20% higher. Aura Biosciences Inc (AURA) has a Forward Free Cash Flow (FCF) yield of approximately -21.38%. Compared to its 3-year average FCF yield of -18.14%, the current FCF yield is approximately 17.83% lower. Relative to its 5-year average FCF yield of -16.00% , the current FCF yield is about 33.61% lower.